WASHINGTON — A routine congressional hearing on Wednesday morning took an unexpected turn when Representative Ted Lieu methodically questioned FBI Director Kash Patel about the handling of investigative files connected to Jeffrey Epstein, exposing gaps in oversight and raising new questions about document classification decisions inside the bureau.

The hearing of the House Judiciary Committee had begun as a procedural review focused on budget allocations and departmental operations at the Federal Bureau of Investigation. For more than an hour, the exchanges between lawmakers and witnesses followed a familiar script: prepared questions, carefully worded answers, and little sign of controversy.

That changed when Lieu, a former Air Force judge advocate known for his precise questioning style, began a line of inquiry focused on how major case files are reviewed at the highest levels of the bureau.

“Walk me through how evidence review works inside the FBI at the director level,” Lieu asked Patel, who had taken his seat earlier in the morning flanked by legal advisers.

Patel initially appeared comfortable, explaining that matters with significant national implications are elevated through the chain of command and reviewed by senior leadership.

But Lieu pressed further, asking whether investigations of major public interest — specifically the Epstein case — would typically reach the director’s desk in full.

Patel responded that “relevant portions” of such investigations are brought to his attention through staff briefings. Lieu paused, then asked a sharper question: whether the Epstein file itself had come to Patel’s desk.

The director acknowledged reviewing materials provided by his team but stopped short of saying he had examined the full investigative file.

The exchange drew the attention of committee members and reporters in the chamber, many of whom had been only loosely following the earlier proceedings.

Lieu then introduced a document he described as an internal FBI assessment from March of the previous year, which he said identified 81 individuals referenced in investigative materials tied to Epstein’s network. According to Lieu, the list categorized those individuals into several groups, including domestic political figures, corporate executives, foreign nationals and members of media or institutional circles.

Patel declined to confirm the existence of the document in an open session, citing classification restrictions.

Lieu did not immediately dispute the claim but instead shifted his focus to investigative resources. He asked how many agents had been assigned to review Epstein-related materials over the past year.

Patel estimated that between eight and twelve personnel had been working on the matter at any given time.

Lieu compared that number to the thousands of agents who had participated in investigations related to the January 6 attack on the Capitol, suggesting that the Epstein inquiry had been handled with a far smaller investigative footprint.

Patel replied that investigative effectiveness is not determined solely by the number of personnel involved and that specialized teams are often used in complex cases.

The questioning continued with Lieu seeking details about who within the bureau had access to the full, unredacted investigative file. Patel said access was limited to a “smaller specialized subset” of agents, estimating that three or four individuals had clearance to review the complete record.

Lieu noted that the director himself had relied largely on summaries rather than direct review of the full file.

Later in the exchange, Lieu presented another document, which he said showed that hundreds of records related to the investigation had been reclassified earlier this year.

Patel confirmed that the final authority for such classification decisions rests with the director’s office but emphasized that the process involves multiple layers of internal review and legal consultation.

Seated nearby during the hearing was Pam Bondi, who appeared before the committee in her role overseeing the Justice Department. When Lieu asked whether the U.S. Department of Justice had been informed of the classification changes, Bondi said standard interagency protocols had been followed but declined to comment on specific documents.

Lieu concluded his questioning without dramatic statements, summarizing several key points raised during the exchange: the number of agents assigned to the investigation, the limited access to unredacted files, and the recent reclassification of hundreds of documents.

“What exactly is being protected here,” he asked, “and from whom?”

Neither Patel nor Bondi answered directly in the moment, and the hearing soon moved on to other committee members.

After the session, Bondi departed the chamber before the hearing officially ended and did not take questions from reporters. A brief statement from her office later in the day cited “ongoing legal sensitivities” surrounding the investigation.

Patel did not issue a public statement following the hearing.

The documents referenced by Lieu were entered into the congressional record, and additional hearings related to oversight of federal investigations are expected in the coming weeks.

For now, the exchange stands as one of the most pointed moments in an otherwise routine hearing — a reminder that even procedural oversight sessions can unexpectedly surface unresolved questions about some of the government’s most scrutinized investigations.